Krafted Therapeutics, Inc.

Krafted Therapeutics is a pharmaceutical development company advancing investigational botanical drug programs within established FDA regulatory pathways.

The company’s lead program, Primustatin™, is being developed under the FDA Botanical Drug Development framework utilizing a 505(b)(2) regulatory strategy.

Long-Term Vision

Krafted Therapeutics seeks to advance regulated botanical therapeutics within modern preventive medicine, combining botanical origin with pharmaceutical standards, predictable dosing, and clinical accountability.